by rss feed | Jan 5, 2021 | Camillo Ricordi, COVID-19, MSCs Mesenchymal stem stromal cells, News Feeds, Stem cells for COVID-19, umbilical cord stem cells
A new paper today in Stem Cells Translational Medicine on a small COVID-19 Phase 1/2a trial using an umbilical cord stem cell product reports a surprising degree of possible efficacy. What’s the scoop here and could there be some hype in the media about this new...
by rss feed | Dec 22, 2020 | COVID-19, Mesoblast, News Feeds, Remestemcel-l, stem cell clinical trials, Stem cells for COVID-19
I’ve been closely following the arena of stem cells for COVID-19 since the pandemic broke including the efforts of Mesoblast. Mesoblast unlikely to meet primary endpoints in Phase III COVID trial Now, the firm got bad news as its DSMB reported that they are...
by rss feed | Dec 6, 2020 | Aging, cancer stem cells, COVID-19, COVID-19 vaccine, CRISPR soldiers, DeepMind, News Feeds, retractions, stem cell banking, Structural Biology, Vision, Zubin Master
This week we have some interesting new reading including both on the stem cell basic and translational fronts as well as on COVID-19 vaccines. COVID-19 vaccine considerations From Derek Lowe at In The Pipeline on COVID-19 vaccine expectations at Science Translational...
by rss feed | Dec 6, 2020 | Aging, cancer stem cells, COVID-19, COVID-19 vaccine, CRISPR soldiers, DeepMind, News Feeds, retractions, stem cell banking, Structural Biology, Vision, Zubin Master
This week we have some interesting new reading including both on the stem cell basic and translational fronts as well as on COVID-19 vaccines. COVID-19 vaccine considerations From Derek Lowe at In The Pipeline on COVID-19 vaccine expectations at Science Translational...
by rss feed | Nov 18, 2020 | antibody-dependent enhancement, COVID-19, Moderna, Moderna COVID-19 vaccine, mRNA-1273, News Feeds, Pfizer COVID vaccine, reverse transcriptase, RNA vaccine for COVID-19, RNA vaccine risk, vaccines
I’m not a virologist, but I’m still getting asked these days about what the risks might be from the new generation of RNA vaccines for COVID-19. Approaching this question instead as a biologist and genetics/genomics researcher, I can see a handful of at...
by rss feed | Nov 18, 2020 | antibody-dependent enhancement, COVID-19, Moderna, Moderna COVID-19 vaccine, mRNA-1273, News Feeds, Pfizer COVID vaccine, reverse transcriptase, RNA vaccine for COVID-19, RNA vaccine risk, vaccines
I’m not a virologist, but I’m still getting asked these days about what the risks might be from the new generation of RNA vaccines for COVID-19. Approaching this question instead as a biologist and genetics/genomics researcher, I can see a handful of at...
